Infant formula will continue to grow and deliver good returns. That doesnt mean expansion into other regions should stop.
USA is an important market and its so big that you dont want to go in there when patents are about to expire.
The ceo and the directors have obviously such a good vision for the company
Come back when you see strong revenue numbers and ebitda in 10 years time. 5 years time I will be happy if it can generate 10m ebitda. Dont forget a brand takes a long time to develop. We have got it in aus nz and china now and breaking into usa is very important for world wide recognition
China Only, No US expansion, page-7
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.88 |
Change
0.000(0.00%) |
Mkt cap ! $4.973B | |||
| Open | High | Low | Value | Volume |
| $6.90 | $6.90 | $6.80 | $7.266M | 1.060M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12501 | $6.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.88 | 33092 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |